Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-25T20:20:49.806Z Has data issue: false hasContentIssue false

Exploratory study on the effectiveness of integrative neurocognitive remediation therapy (iNCRT) for cancer survivors

Published online by Cambridge University Press:  01 September 2022

A. Rogiers*
Affiliation:
CHU Brugmann, Psychiatry, Brussels, Belgium UZ Brussels, Oncology, Brussels, Belgium
D. Kyndt
Affiliation:
CHU Brugmann, Psychiatry, Brussels, Belgium
S. Van Eycken
Affiliation:
CHU Brugmann, Psychiatry, Brussels, Belgium
J.-C. Le Febvre
Affiliation:
CHU Brugmann, Psychiatry, Brussels, Belgium
M. Brohee
Affiliation:
CHU Brugmann, Psychiatry, Brussels, Belgium
C. Degols
Affiliation:
CHU Brugmann, Psychiatry, Brussels, Belgium
C. Fontaine
Affiliation:
UZ Brussels, Oncology, Brussels, Belgium
B. Neyns
Affiliation:
UZ Brussels, Oncology, Brussels, Belgium
C. Kornreich
Affiliation:
CHU Brugmann, Psychiatry, Brussels, Belgium
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Cancer survivors frequently report suffering from neurocognitive impairment, that persists after physical recovery from their disease. Cognitive impairment is associated with important emotional disturbances, socio-professional consequences and diminished quality of life.

Objectives

This observational study aims to assess the effectives of an integrative neurocognitive remediation therapy (iNRCT), offered as a 12-week program (1day/week), organized within our Cognitive Remediation Clinic. The iNCRT combines personalized computerized cognitive training and neurocognitive strategy training, with group sessions of physical exercise, mindfulness, and cognitive behavior therapy (CBT).

Methods

The assessment before and after NCRT includes neuropsychological testing (10 subtests), assessment of daily functioning and subjective neurocognitive function (NCF).

Results

Out of 16 eligible cancer survivors, 12 patients were recruited and 11 completed the iNCRT; median age 53 years [range, 41-71]; 3 patients had a prior history of a central nervous system tumor, 5 patients of breast cancer, 2 patients of stage-IV melanoma, and 1 patient of gastric cancer. After iNCRT subjective NCF did not improve significantly (p=0.13) according to the Cognitive Failure Questionnaire. However neuropsychological assessment revealed an improvement on ≥ 1 impaired subtest in all patients; 6 patients improved on ≥ 4 impaired subtests. Improvement was most prominent in long-term verbal and visual memory, working memory and executive function. All patients reported a clinical benefit in their daily function after completion of iNCRT.

Conclusions

Our iNRCT, which combines personalized neurocognitive training with physical exercise, mindfulness and CBT can be an effective therapeutic model for treating neurocognitive impairment in cancer survivors, with a clinically relevant impact on their daily function.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.